☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
EGFR Exon 20 Insertion Mutations
Janssen Report MAA Submission of Amivantamab to EMA for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutation...
December 29, 2020
Takeda's Mobocertinib (TAK-788) Receives the US FDA's Breakthrough Therapy Designation for NSCLC Patients with EGFR Exon 20 Insert...
April 28, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.